Revvity Inc. $RVTY Shares Purchased by SG Americas Securities LLC

SG Americas Securities LLC raised its stake in Revvity Inc. (NYSE:RVTY) by 531.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,947 shares of the company’s stock after acquiring an additional 36,149 shares during the period. SG Americas Securities LLC’s holdings in Revvity were worth $3,764,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in RVTY. CYBER HORNET ETFs LLC bought a new stake in shares of Revvity in the 2nd quarter worth approximately $32,000. MUFG Securities EMEA plc bought a new position in Revvity during the 2nd quarter worth $34,000. UMB Bank n.a. increased its position in Revvity by 138.8% in the second quarter. UMB Bank n.a. now owns 406 shares of the company’s stock worth $39,000 after buying an additional 236 shares during the period. CVA Family Office LLC lifted its stake in Revvity by 79.0% in the second quarter. CVA Family Office LLC now owns 410 shares of the company’s stock valued at $40,000 after buying an additional 181 shares during the last quarter. Finally, Headlands Technologies LLC acquired a new position in shares of Revvity during the second quarter valued at $49,000. 86.65% of the stock is owned by institutional investors.

Revvity Trading Up 2.8%

Revvity stock opened at $104.57 on Monday. Revvity Inc. has a 12-month low of $81.36 and a 12-month high of $128.29. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.75 and a quick ratio of 1.44. The stock has a market capitalization of $11.86 billion, a PE ratio of 52.55, a price-to-earnings-growth ratio of 3.19 and a beta of 1.05. The firm has a 50 day simple moving average of $98.08 and a 200-day simple moving average of $94.05.

Revvity (NYSE:RVTY) last released its earnings results on Monday, October 27th. The company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.14 by $0.04. The firm had revenue of $698.95 million during the quarter, compared to the consensus estimate of $699.75 million. Revvity had a return on equity of 7.52% and a net margin of 8.44%.The firm’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.28 earnings per share. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS. As a group, equities research analysts expect that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity announced that its Board of Directors has authorized a share buyback plan on Monday, October 27th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to repurchase up to 8.7% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s management believes its shares are undervalued.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 6th. Investors of record on Friday, January 16th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, January 16th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is currently 14.07%.

Analysts Set New Price Targets

A number of research firms recently weighed in on RVTY. The Goldman Sachs Group initiated coverage on shares of Revvity in a report on Tuesday, December 9th. They issued a “neutral” rating and a $105.00 price objective on the stock. Weiss Ratings restated a “sell (d)” rating on shares of Revvity in a research note on Monday, December 29th. Evercore ISI reiterated an “outperform” rating on shares of Revvity in a research report on Monday, January 5th. Barclays increased their price objective on Revvity from $105.00 to $115.00 and gave the stock an “overweight” rating in a report on Monday, December 15th. Finally, Wells Fargo & Company lifted their target price on Revvity from $102.00 to $107.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Revvity currently has an average rating of “Hold” and a consensus price target of $113.91.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.